Exposure to paraben and triclosan and allergic diseases in Tokyo: A pilot cross-sectional study.

Allergy Atopic dermatitis Child Paraben Triclosan Wheezing

Journal

Asia Pacific allergy
ISSN: 2233-8276
Titre abrégé: Asia Pac Allergy
Pays: Netherlands
ID NLM: 101561954

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 13 01 2018
accepted: 14 01 2018
entrez: 12 2 2019
pubmed: 12 2 2019
medline: 12 2 2019
Statut: epublish

Résumé

Previous studies have reported that exposure to paraben (Pb) and triclosan (TCS) is associated with allergies. However, Pb and TCS exposure in the Japanese population is not fully understood. The present study was aimed to examine such exposure among Japanese individuals with allergic diseases. This cross-sectional study included the International Study of Asthma and Allergies in Childhood questionnaire survey to evaluate allergic outcomes and the collection of urine samples to examine Pb and TCS exposure. Pb containing daily commodities was used in 84.8% children. Pb use was positively associated with current atopic dermatitis (adjusted odds ratio, 4.61; 95% confidence interval, 1.23-17.3). Urinary Pb concentrations were increased significantly in those with current atopic dermatitis (AD) (median, 4.58 vs. 0; Urinary levels of Pb were associated with current AD in children. We should pay more attention about Pb and TCS.

Sections du résumé

BACKGROUND BACKGROUND
Previous studies have reported that exposure to paraben (Pb) and triclosan (TCS) is associated with allergies. However, Pb and TCS exposure in the Japanese population is not fully understood.
OBJECTIVES OBJECTIVE
The present study was aimed to examine such exposure among Japanese individuals with allergic diseases.
METHODS METHODS
This cross-sectional study included the International Study of Asthma and Allergies in Childhood questionnaire survey to evaluate allergic outcomes and the collection of urine samples to examine Pb and TCS exposure.
RESULTS RESULTS
Pb containing daily commodities was used in 84.8% children. Pb use was positively associated with current atopic dermatitis (adjusted odds ratio, 4.61; 95% confidence interval, 1.23-17.3). Urinary Pb concentrations were increased significantly in those with current atopic dermatitis (AD) (median, 4.58 vs. 0;
CONCLUSION CONCLUSIONS
Urinary levels of Pb were associated with current AD in children. We should pay more attention about Pb and TCS.

Identifiants

pubmed: 30740353
doi: 10.5415/apallergy.2019.9.e5
pii: 2019090103
pmc: PMC6365653
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e5

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

Conflict of Interest: The authors have no financial conflicts of interest.

Références

Thorax. 2000 Aug;55 Suppl 1:S2-10
pubmed: 10943631
Environ Health Perspect. 2006 Dec;114(12):1843-6
pubmed: 17185273
Environ Health Perspect. 2008 Mar;116(3):303-7
pubmed: 18335095
Environ Health Perspect. 2010 May;118(5):679-85
pubmed: 20056562
JAMA. 2011 Apr 13;305(14):1400-1
pubmed: 21486968
J Allergy Clin Immunol. 2012 Aug;130(2):453-60.e7
pubmed: 22704536
Allergy. 2013 Jan;68(1):84-91
pubmed: 23146048
Environ Sci Technol. 2013 Dec 17;47(24):14442-9
pubmed: 24261694
World Allergy Organ J. 2014 May 19;7(1):12
pubmed: 24940476
J Allergy Clin Immunol. 2014 Oct;134(4):824-830.e6
pubmed: 25282564
Allergy Asthma Proc. 2014 Nov-Dec;35(6):475-81
pubmed: 25584915
Reprod Toxicol. 2015 Apr;52:93-100
pubmed: 25728410
Allergy. 2015 Jun;70(6):653-60
pubmed: 25753462
Int J Hyg Environ Health. 2016 May;219(3):311-6
pubmed: 26765087
Reprod Toxicol. 2016 Aug;63:107-13
pubmed: 27189314
Allergy. 2017 Nov;72(11):1768-1777
pubmed: 28281298
Curr Probl Pediatr Adolesc Health Care. 2017 May;47(5):107-118
pubmed: 28526231
Pediatr Allergy Immunol. 2017 Dec;28(8):746-753
pubmed: 28892561
Nat Immunol. 2017 Sep 19;18(10):1076-1083
pubmed: 28926539
J Allergy Clin Immunol. 2018 Jul;142(1):269-278.e15
pubmed: 29111213
Pediatr Allergy Immunol. 2018 Sep;29(6):657-660
pubmed: 29882265
J Allergy Clin Immunol. 2018 Sep 5;:null
pubmed: 30194988
Allergy. 2018 Oct 24;:null
pubmed: 30353933
Eur Respir J. 1995 Mar;8(3):483-91
pubmed: 7789502

Auteurs

Motoko Mitsui-Iwama (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.

Kiwako Yamamoto-Hanada (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Yuma Fukutomi (Y)

Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara Hospital, Kanagawa, Japan.

Ryoji Hirota (R)

Graduate School of Health Science, Matsumoto University, Nagano, Japan.

Go Muto (G)

Department of Hygiene, Kitasato University School of Medicine, Kanagawa, Japan.

Takeshi Nakamura (T)

Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories Ltd., Wakayama, Japan.

Takahiro Yoshikawa (T)

Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories Ltd., Wakayama, Japan.

Hiroyuki Nakamura (H)

Department of Environmental and Preventive Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

Masashi Mikami (M)

Division of Biostatistics, Department of Data Management, Center for Clinical Research and Development, National Center for Child Health and Development, Tokyo, Japan.

Ichiro Morioka (I)

Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.

Yukihiro Ohya (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Classifications MeSH